197 related articles for article (PubMed ID: 23239242)
1. The current status of positron emission mammography in breast cancer diagnosis.
Kalles V; Zografos GC; Provatopoulou X; Koulocheri D; Gounaris A
Breast Cancer; 2013 Apr; 20(2):123-30. PubMed ID: 23239242
[TBL] [Abstract][Full Text] [Related]
2. Impact of the diagnostic methods on the therapeutic strategies.
Greco M; Agresti R; Giovanazzi R
Q J Nucl Med; 1998 Mar; 42(1):66-80. PubMed ID: 9646647
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic performance of dedicated positron emission mammography using fluorine-18-fluorodeoxyglucose in women with suspicious breast lesions: a meta-analysis.
Caldarella C; Treglia G; Giordano A
Clin Breast Cancer; 2014 Aug; 14(4):241-8. PubMed ID: 24472718
[TBL] [Abstract][Full Text] [Related]
4. Whole-body magnetic resonance imaging and positron emission tomography-computed tomography in oncology.
Schmidt GP; Kramer H; Reiser MF; Glaser C
Top Magn Reson Imaging; 2007 Jun; 18(3):193-202. PubMed ID: 17762383
[TBL] [Abstract][Full Text] [Related]
5. Evolving role of imaging modalities in inflammatory breast cancer.
Le-Petross CH; Bidaut L; Yang WT
Semin Oncol; 2008 Feb; 35(1):51-63. PubMed ID: 18308146
[TBL] [Abstract][Full Text] [Related]
6. MRI and PET/CT of patients with bone metastases from breast carcinoma.
Grankvist J; Fisker R; Iyer V; Fründ ET; Simonsen C; Christensen T; Stenbygaard L; Ewertz M; Larsson EM
Eur J Radiol; 2012 Jan; 81(1):e13-8. PubMed ID: 21227614
[TBL] [Abstract][Full Text] [Related]
7. Screening, imaging, and image-guided biopsy techniques for breast cancer.
Smetherman DH
Surg Clin North Am; 2013 Apr; 93(2):309-27. PubMed ID: 23464688
[TBL] [Abstract][Full Text] [Related]
8. Results of preliminary clinical trials of the positron emission mammography system PEM-I: a dedicated breast imaging system producing glucose metabolic images using FDG.
Murthy K; Aznar M; Thompson CJ; Loutfi A; Lisbona R; Gagnon JH
J Nucl Med; 2000 Nov; 41(11):1851-8. PubMed ID: 11079494
[TBL] [Abstract][Full Text] [Related]
9. A prospective diagnostic accuracy study of 18F-fluorodeoxyglucose positron emission tomography/computed tomography, multidetector row computed tomography, and magnetic resonance imaging in primary diagnosis and staging of pancreatic cancer.
Kauhanen SP; Komar G; Seppänen MP; Dean KI; Minn HR; Kajander SA; Rinta-Kiikka I; Alanen K; Borra RJ; Puolakkainen PA; Nuutila P; Ovaska JT
Ann Surg; 2009 Dec; 250(6):957-63. PubMed ID: 19687736
[TBL] [Abstract][Full Text] [Related]
10. A molecular approach to breast imaging.
Fowler AM
J Nucl Med; 2014 Feb; 55(2):177-80. PubMed ID: 24434288
[TBL] [Abstract][Full Text] [Related]
11. Positron Emission Tomography (PET) and breast cancer in clinical practice.
Lavayssière R; Cabée AE; Filmont JE
Eur J Radiol; 2009 Jan; 69(1):50-8. PubMed ID: 18814983
[TBL] [Abstract][Full Text] [Related]
12. Computed tomography, magnetic resonance imaging and 11C-metomidate positron emission tomography for evaluation of adrenal incidentalomas.
Hennings J; Hellman P; Ahlström H; Sundin A
Eur J Radiol; 2009 Feb; 69(2):314-23. PubMed ID: 18082990
[TBL] [Abstract][Full Text] [Related]
13. Integrated contrast-enhanced diagnostic whole-body PET/CT as a first-line restaging modality in patients with suspected metastatic recurrence of breast cancer.
Dirisamer A; Halpern BS; Flöry D; Wolf F; Beheshti M; Mayerhoefer ME; Langsteger W
Eur J Radiol; 2010 Feb; 73(2):294-9. PubMed ID: 19181468
[TBL] [Abstract][Full Text] [Related]
14. A preliminary report of breast cancer screening by positron emission mammography.
Yamamoto Y; Tasaki Y; Kuwada Y; Ozawa Y; Inoue T
Ann Nucl Med; 2016 Feb; 30(2):130-7. PubMed ID: 26586370
[TBL] [Abstract][Full Text] [Related]
15. Breast cancer imaging devices.
Moadel RM
Semin Nucl Med; 2011 May; 41(3):229-41. PubMed ID: 21440698
[TBL] [Abstract][Full Text] [Related]
16. The positron emission mammography/tomography breast imaging and biopsy system (PEM/PET): design, construction and phantom-based measurements.
Raylman RR; Majewski S; Smith MF; Proffitt J; Hammond W; Srinivasan A; McKisson J; Popov V; Weisenberger A; Judy CO; Kross B; Ramasubramanian S; Banta LE; Kinahan PE; Champley K
Phys Med Biol; 2008 Feb; 53(3):637-53. PubMed ID: 18199907
[TBL] [Abstract][Full Text] [Related]
17. Improved detection of breast cancer on FDG-PET cancer screening using breast positioning device.
Kaida H; Ishibashi M; Fujii T; Kurata S; Ogo E; Tanaka M; Hayabuchi N
Ann Nucl Med; 2008 Feb; 22(2):95-101. PubMed ID: 18311533
[TBL] [Abstract][Full Text] [Related]
18. Imaging sensitivity of dedicated positron emission mammography in relation to tumor size.
Eo JS; Chun IK; Paeng JC; Kang KW; Lee SM; Han W; Noh DY; Chung JK; Lee DS
Breast; 2012 Feb; 21(1):66-71. PubMed ID: 21871801
[TBL] [Abstract][Full Text] [Related]
19. Utility of 2-[18F] fluoro-2-deoxy-D-glucose positron emission tomography and positron emission tomography/computed tomography imaging in the preoperative staging of head and neck squamous cell carcinoma.
Roh JL; Yeo NK; Kim JS; Lee JH; Cho KJ; Choi SH; Nam SY; Kim SY
Oral Oncol; 2007 Oct; 43(9):887-93. PubMed ID: 17207656
[TBL] [Abstract][Full Text] [Related]
20. Radiologist views of positron emission mammography.
Greene LR; George RF
Radiol Technol; 2012; 84(1):18-30. PubMed ID: 22988260
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
